Evidence map›Paper›PMID 31932995›Full record

Trial reportStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2020

Duration-dependent margins for prostate radiotherapy-a practical motion mitigation strategy.

Eric Pei Ping Pang, Kellie Knight, Sung Yong Park, Weixiang Lian, Zubin Master, Marilyn Baird, Jason Wei Xiang Chan, Michael Lian Chek Wang, Terence Wee Kiat Tan, Melvin L K Chua and 4 more

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Eric Pei Ping PangDivision of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, 169610, Singapore, Singapore. eric.pang.p.p@nccs.com.sg.ORCID http://orcid.org/0000-0001-7930-926X
Kellie KnightFaculty of Medicine, Nursing and Health Sciences, Department of Medical Imaging & Radiation Sciences, Monash University, Wellington Road, Clayton VIC, 3800, Melbourne, Australia.
Sung Yong ParkDivision of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, 169610, Singapore, Singapore.
Weixiang LianDivision of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, 169610, Singapore, Singapore.
Zubin MasterDivision of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, 169610, Singapore, Singapore.
Marilyn BairdFaculty of Medicine, Nursing and Health Sciences, Department of Medical Imaging & Radiation Sciences, Monash University, Wellington Road, Clayton VIC, 3800, Melbourne, Australia.
Jason Wei Xiang ChanDivision of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, 169610, Singapore, Singapore.
Michael Lian Chek WangDivision of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, 169610, Singapore, Singapore.
Terence Wee Kiat TanDivision of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, 169610, Singapore, Singapore.
Melvin L K ChuaDivision of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, 169610, Singapore, Singapore.
Eu Tiong ChuaDivision of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, 169610, Singapore, Singapore.
Wen Shen LooiDivision of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, 169610, Singapore, Singapore.
Wen Long NeiDivision of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, 169610, Singapore, Singapore.
Jeffrey Kit Loong TuanDivision of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, 169610, Singapore, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveThe magnitude of intra-fractional prostate displacement (change from initial position over time) is associated with the duration of the patient lying on the radiotherapy treatment couch. This study reports a minute-by-minute association and calculates the impact of this displacement on duration-dependent margins using real-time intra-fractional position data monitored by four-dimensional transperineal ultrasound (4D TPUS). MATERIALS AND

methodsA total of 55 patients were recruited prospectively. Intra-fractional position of the prostate was monitored in real-time using a 4D TPUS Clarity® system. A total of 1745 monitoring sessions were analysed. Van Herk's margin recipe (2.5∑ + 1.64((σ

resultsThe mean intra-fractional position was 0.76 mm Inferior (Inf), 0 mm Lateral (Lat) and 0.94 mm Posterior (Post) at the 15th minute. A minimum margin expansion of 2.42 mm (Superior/Inf), 1.02 mm (Left/Right) and 2.65 mm (Anterior/Post) was required for an 8‑minute treatment compared to 4.29 mm (Sup/Inf), 1.84 mm (Lt/Rt) and 4.63 mm (Ant/Post) for a 15-minute treatment. The required margin expansion increased linearly (R

conclusionWe report our experience in deriving the minimum duration-dependant margin to generate the required planning target volume for prostate radiotherapy. The required margin increases linearly in all directions within the 15-min duration; thus, the margin will depend on the duration of the technique chosen (IMRT/VMAT/3DCRT/proton).

Indexed as

ArtifactsRadiotherapy, Intensity-ModulatedAdenocarcinomaComputer SystemsHumansMaleMotionPatient PositioningPerineumProstateProstatic NeoplasmsRadiotherapy Setup ErrorsTime FactorsUltrasonographyIntra-fractional prostate displacementMarginsProstate cancerReal-time trackingTransperineal ultrasound

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.